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The mesencephalic (or midbrain) locomotor region (MLR) was first described in 1966 
by Shik and colleagues, who demonstrated that electrical stimulation of this region 
induced locomotion in decerebrate (intercollicular transection) cats. The pedunculo-
pontine tegmental nucleus (PPT) cholinergic neurons and midbrain extrapyramidal area 
(MEA) have been suggested to form the neuroanatomical basis for the MLR, but direct 
evidence for the role of these structures in locomotor behavior has been lacking. Here, 
we tested the hypothesis that the MLR is composed of non-cholinergic spinally projecting 
cells in the lateral pontine tegmentum. Our results showed that putative MLR neurons 
medial to the PPT and MEA in rats were non-cholinergic, glutamatergic, and express 
the orexin (hypocretin) type 2 receptors. Fos mapping correlated with motor behaviors 
revealed that the dorsal and ventral MLR are activated, respectively, in association with 
locomotion and an erect posture. Consistent with these findings, chemical stimulation 
of the dorsal MLR produced locomotion, whereas stimulation of the ventral MLR caused 
standing. Lesions of the MLR (dorsal and ventral regions together) resulted in cataplexy 
and episodic immobility of gait. Finally, trans-neuronal tracing with pseudorabies virus 
demonstrated disynaptic input to the MLR from the substantia nigra via the MEA. 
These findings offer a new perspective on the neuroanatomic basis of the MLR, and 
suggest that MLR dysfunction may contribute to the postural and gait abnormalities in 
Parkinsonism.
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introduction
Work by Rhines and Magoun (1) provided the first indication that the reticular formation might 
participate in motor control by demonstrating that electrical stimulation of the reticular forma-
tion in decerebrate cats produced changes in muscle tone. Later work by Sprague and Chambers 
(2) showed that electrical stimulation of the reticular formation in freely moving, unanesthetized 
cats produced a variety of complex postural and motor behaviors, including circling, standing, 
and assuming sleep postures. In 1966, Shik and colleagues (3) showed that electrical stimulation 
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within a confined region of the dorsal reticular formation (at the 
mesopontine junction) triggered walking and even galloping in 
otherwise immobile decerebrate cats. This confined area of the 
reticular formation was subsequently termed the mesencephalic 
locomotor region (MLR), and was considered a part of the cunei-
form nucleus. Cuneiform nucleus is, however, an older term that 
included much of the mesopontine reticular formation. The term 
is often confused with the much smaller and better delineated 
nucleus of the same name used in modern literature, based upon 
the Berman cat atlas (4), which does not contain the MLR. To 
end this confusion, Skinner, Garcia-Rill, and colleagues refined 
the anatomical boundary of the MLR in rats to a more restricted 
region of the mesopontine reticular formation that included 
cholinergic neurons of the pedunculopontine tegmental nucleus 
(PPT or PPN) (5). Cholinergic PPT neurons have since been 
widely considered a key anatomical element of the anatomic and 
physiologic MLR (5).
Interestingly, however, lesions of neither the PPT nor the 
cuneiform nucleus block locomotion induced by stimulation 
of the lateral hypothalamus, a known input to the MLR (6, 7). 
Moreover, while cholinergic neurons of the PPT innervate the 
lower brainstem reticular formation, they provide few if any spinal 
projections (8). On the other hand, previous studies have revealed 
a band of non-cholinergic neurons just medial to the PPT that 
project directly to both the ventral horn of the spinal cord and to 
the ventromedial medulla (VMM) (8–11). Interestingly, this pon-
tine cell group, which lies just ventral and medial to the PPT and 
ventral to the cuneiform nucleus, fits the general location originally 
proposed for the MLR. We have recently recorded from neurons 
in the lateral pontine tegmentum (LPT) by means of antidromic 
responses to spinal cord stimulation in freely moving animals, 
and found that the spinally projecting neurons fired in a bursting 
pattern with motor behavior while the non-spinally projecting 
neurons did not fire in association with motor behavior (12). Due 
to their connections with two crucial motor areas (i.e., the VMM 
and the spinal ventral horn), we hypothesized that these pontine 
spinally projecting neurons of the LPT are excellent candidates 
for the neuronal basis of the MLR.
The LPT contains substantial numbers of orexin- 
immunoreactive (-ir) terminals and high levels of them express 
the orexin 2 (OX2) receptor, whereas PPT cholinergic neurons 
express OX1 receptors (9, 13). Orexin neurons fire fastest during 
active locomotion (14, 15) and injection of an orexin-A agonist 
into the LPT region is reported to elicit locomotion in decerebrate 
cats (16), providing further support for the idea that the neurons 
in the LPT are modulated by orexin. Orexin is exclusively synthe-
sized in the lateral hypothalamus (17), and studies in animals and 
humans have demonstrated that the disruption of orexin signaling 
(which is presumably excitatory) causes narcolepsy and cataplexy 
(sudden loss of muscle tone during wakefulness). Consistent with 
this, lesions of the LPT result in cataplexy in rats (9) and humans 
(18–22). These observations suggest that MLR neurons in the 
LPT may be important in both maintaining postural muscle tone 
against gravity and facilitating locomotion.
Both normal erect posture and gait initiation are impaired in 
patients with Parkinson’s disease (PD). And both the akinesia and 
gait freezing of PD have been attributed to inhibition of the PPT 
by overactive GABAergic neurons in the substantia nigra pars 
reticulata (SNr) and the internal segment of the globus pallidus 
(GPi in primates or endopeduncular nucleus in rats) (23). One 
recent study reported that deep brain stimulation (DBS) of the 
PPT region improved bradykinesia and gait in patients with PD 
(24). However, the pontine target of descending SNr/GPi input is 
in fact the midbrain extrapyramidal area (MEA), a region imme-
diately medially adjacent to the cholinergic neurons of the PPT. 
This site, as well as the adjacent LPT reticulospinal neurons, may 
therefore have been activated by PPT-targeted DBS stimulation 
in the patients with PD. Thus, while the circuitry that causes the 
gait and postural disorders in PD remains poorly defined, it is 
possible that the ameliorative effects of DBS in PPT may depend 
most critically upon activation of motor circuitry in the MLR.
Given the foregoing, delineating the neuronal circuitry of 
the MLR may have significant implications for understanding 
fundamental issues of motor control and may provide a frame-
work for understanding the circuit pathology of cataplexy and 
Parkinsonism. In the first part of the present study, we defined 
the MLR through the combined application of neuronal trac-
ers, Fos mapping, chemical stimulation studies, and behavioral 
characterizations. In the second part of the study, we correlated 
chemical activation and lesions of the MLR with the occurrence 
of cataplexy and examined connections between the MLR and the 
orexinergic system. In the third part, we examine the connectivity 
of the MLR with basal ganglia output structures and explored 
the physiological and pathological implications of this circuitry. 
The results of the present study provide a new perspective on the 
neuroanatomic MLR, as well as provide a neuronal framework 
for understanding cataplexy and Parkinsonian akinesia and gait 
impairment.
results
Pontine spinally Projecting neurons contain 
glutamate and Orexin 2 receptors
We hypothesized that the potent locomotor effects of the MLR 
might be due to a direct spinal projection, and so defined a 
candidate cell population by injecting 20 nl of 10% Fluorogold 
(FG) into the spinal ventral horn and intermediate gray matter 
at the C8-T1 level in a series of 10 rats. FG was retrogradely 
transported into a large number of cells in the LPT, forming a 
strip running ventrally from the ventrolateral periaqueductal 
gray (vlPAG) to the region ventromedial to the PPT, with 
ipsilateral predominance. Dual labeling for FG and choline 
acetyltransferase (ChAT) immunoreactivity (Figures  1A,B) 
or for FG and vesicular glutamate transporter 2 (VGLUT2) 
mRNA by in situ hybridization showed that the FG-ir cells were 
exclusively non-cholinergic and almost all the FG-ir neurons 
were glutamatergic (Figures 1A–C). We have previously reported 
descending projections from the LPT mostly to the interneuron 
regions of the ventral horn (laminae VII and VIII) and less to 
motor neurons with a large number of appositions at the cervi-
cal level, fewer at the lumbar level, and fewest at the thoracic 
level (11). We hypothesized that these non-cholinergic and 
glutamatergic reticulospinal projections provide a marker for 
the neuronal population that constitutes the MLR.
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chemical stimulation of the Mlr induces 
locomotor and Postural Behaviors
To determine whether the cells in the region defined by the spinally 
projecting neurons were involved in locomotion, we studied 
whether focal stimulation of the LPT could induce any postural 
or locomotor behaviors. Under brief anesthesia with 2% isoflurane, 
rats received a stereotaxically placed injection of 3 nl of 10% ibotenic 
acid unilaterally in either the dorsal or ventral MLR (n = 5 at each 
site; Figure 2A). About 2 min after the termination of isoflurane 
in both groups, rats began circling toward the side contralateral 
to the injection site, and this behavior persisted for at least 3 h. At 
the end of 4 h, animals were reanesthetized with chloral hydrate 
and after perfusion with 10% formalin, the brains were removed 
and stained for Fos immunoreactivity and Nissl counterstained. 
Because of the short time after ibotenic acid injection and small 
volume (3 nl), there was no visible cellular injury and Fos-ir cells 
were visible in the ipsilateral but not the contralateral MLR region 
(Figure 2A). Fos was not expressed in the PPT cholinergic neurons 
(Figure 2B). In the spinal cord, Fos was seen in ChAT-ir motor 
neurons in the ventral horn ipsilateral but not contralateral to 
the stimulation site (Figures 2C,D). The stimulation of ipsilateral 
spinal motor neurons likely caused contralateral rotation.
Bilateral stimulation of the MLR region with 3 nl of ibotenic 
acid on each side caused continuous rhythmic walking. Animals 
(n = 5) would walk forward at a deliberate, but unhurried pace, 
until they reached a wall, at which point they would stand up 
against the wall. Animals also engaged in rhythmic whisker move-
ment and vocalization.
Mlr control of Motor Behaviors does not 
Depend on the Ventromedial Medulla
It has been hypothesized that the MLR may activate locomo-
tion via projections to the ventromedial medullary reticular 
formation (11, 25). Specifically, Kinjo and colleagues identified 
Figure 1 | Defining the neuroanatomic Mlr. (a) Retrogradely labeled 
(FG) neurons from the ventral horn (C8-T1 level) are seen within the dorsal 
(dMLR) and ventral (vMLR) components of the MLR. Pedunculopontine 
tegmental (PPT) neurons, labeled brown for ChAT, are seen lateral to the 
MLR (a,B). The clear space between them represents the midbrain 
extrapyramidal area (MEA, also see Figure 7) (a, B). Following spinal 
injections of FG, almost all FG-ir MLR neurons (brown) also express VGLUT2 
mRNA (neurons overlaid by silver grains indicated by arrows) (c). Similarly, 
about 50% of CTB-ir cells from the spinal cord (C8-T1) also contain OX2 
mRNA (arrows) (D). Less than 5% of reticulospinal neurons in the ventral 
MLR also contain D2 mRNA (arrows) (e). (F) shows the proposed pontine 
motor neural circuitry.
Figure 2 | Motor effects of Mlr stimulation. (a) Acute injection of 3 nl 
glutamate agonist (10%) ibotenic acid in the MLR region unilaterally induces 
contra-lateral rotation and c-Fos expression (black) in the MLR region, but not 
in PPT cholinergic neurons (brown, at lower left edge of circumscribed area) 
(B). The same stimulation induces Fos in spinal motor neurons (c). Fos is seen 
in spinal cord motor neurons ipsilateral to the stimulation site (D). Lesions of 
the VMM (e) block neither circling behavior nor Fos expression in the motor 
ChAT-ir neurons induced by unilateral MLR stimulation.
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Figure 3 | activation of the Mlr neurons in motor behaviors. (a) Locomotion (on a rotarod for 1 h) induces c-Fos expression in the dorsal MLR but not the 
ventral MLR. (B) Standing posture (2 h) induces c-Fos in the ventral MLR but not the dorsal MLR.
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PPT cholinergic inputs relaying information to the VMM (25). 
Here, we asked whether the MLR-VMM connection makes an 
important contribution to locomotor behavior. To address this, 
we first lesioned the ventral medullary reticular formation using 
injections of orexin-saporin (OX-SAP, 180 μg) (Figure 2E). These 
lesions extended in the rostral-caudal direction approximately 
from AP = −12.0 to −14.0 mm and from the midline 2.0 mm 
laterally (26). After 2 weeks of recovery, the rats received unilateral 
(3 nl) or bilateral (3 nl each site) injections of ibotenic acid into 
the MLR (n =  5 per group). These rats demonstrated patterns 
of circling behavior (unilateral injections) or walking behavior 
(bilateral injections) similar to the control rats, despite almost com-
plete absence of neurons in the ventromedial medullary reticular 
formation (Figure 2E). In addition, Fos was seen in ventral horn 
motor neurons ipsilateral to the ibotenic acid injection sites in the 
lesioned rats. These results are consistent with earlier observations 
that chemical stimulation of the ventral medulla mainly resulted in 
reduction, not augmentation of muscle tone (27), indicating that 
the MLR activation of locomotion does not depend upon a relay 
to the ventral medulla.
activation of c-Fos expression by neurons in the 
Mlr During locomotion and upright Posture
In order to determine which neurons in the MLR region are 
activated during normal gait and posture, we examined Fos expres-
sion in the LPT reticulospinal neurons of rats after locomotor or 
postural behaviors. Animals received an injection of FG into the 
C8-T1 level of the spinal cord, and after recovery, were compelled 
to walk on a rotorod (n = 5, speed of 8.0 RPM) for 1 h or to stand 
(n = 5, restrained vertically in a mesh cylinder) for 2 h, in order 
to mimic locomotor and postural activity seen after injections 
of ibotenic acid into the LPT. Reticulospinal cells were labeled 
for FG (brown) and for Fos (black) by immunohistochemistry in 
rats (n = 5/group). We found that, after performing a locomotor 
activity, Fos was expressed in 67.6 ± 6.8% of the FG-ir neurons 
in the dorsal group and none of the FG-ir neurons in the ventral 
group (Figure 3A). In contrast, following postural activity, Fos 
expression was displayed in 40.6 ±  3.3% of the FG-ir neurons 
in the ventral group of the MLR and none in the dorsal group 
(Figure 3B). Thus, the activity of spinally projecting neurons in 
the dorsal MLR appears to be associated with locomotion, and in 
the ventral MLR with upright posture.
lesions of the Mlr Produce cataplexy and 
immobility attacks
Cataplexy is a disorder in which patients with narcolepsy 
intermittently lose muscle tone and are unable to move during 
wakefulness. This atonia is similar to that seen in rapid eye 
movement (REM) sleep, but occurs during awake. We had 
previously hypothesized that the LPT region, which includes 
the spinally projecting neurons, has a role in generating muscle 
tone, and that it is normally inhibited during REM sleep, but 
that neurons in the LPT might themselves become inhibited 
during narcolepsy, thus allowing atonia (9). To further define 
the role the MLR neurons might play in mediating cataplexy, we 
first determined whether the spinally projecting MLR neurons 
contained the OX2 receptor for orexin (or hypocretin), the 
peptide neurotransmitter whose signaling is lost in narcoleptic 
animals and humans. We injected CTB into the ventral horn 
of the spinal cord at the C8-T1 level, and combined this with 
in situ hybridization for OX2 receptor mRNA in two rats. We 
found that many CTB-ir neurons in the dorsal MLR (44%) and 
ventral MLR (55%) expressed high levels of the OX2R mRNA 
(Figure 1D).
June 2015 | Volume 6 | Article 1406
Sherman et al. Pontine motor circuit
Frontiers in Neurology | www.frontiersin.org
We next placed lesions in the region of the MLR spinally 
projecting neurons using OX-SAP, a toxin that damages neurons, 
presumably by binding to the OX2 receptor. OX-SAP killed MLR 
and non-MLR neurons within 7–10 days, while selectively sparing 
nearby PPT cholinergic neurons (28). Consistent with our earlier 
findings following ibotenic acid lesions in the LPT region (9), 
bilateral OX-SAP lesions of the ventral MLR (n = 25) produced 
frequent cataplectic attacks, on average 10 per night, although 
certain cases with particularly large lesions (Figure 4A) exhibited 
about 15 per night with an average duration of about 80 s each 
(Figures 4B–D). Cataplectic attacks often occurred during feeding 
behavior and were characterized by a sudden drop in muscle tone, 
measured by electromyogram (EMG), during a period of wakeful-
ness as identified by electroencephalogram (EEG). During these 
attacks, rats frequently experienced postural collapse (Figure 4C). 
When these bouts of paralysis lasted more than 30 s, EEG desyn-
chronization was often seen, with a gradual increase in theta power.
Lesions targeting the dorsal part of the MLR caused immobil-
ity attacks lasting up to 30 min during which animals remained 
standing in one place (Figures  4E,F). The initial waking EEG 
would gradually slow into the range of a NREM sleep pattern 
about 15 s after the onset of paralysis. Often wake and sleep EEG 
alternated during the attacks. Although we only recorded EMG 
in cervical muscles, which showed a low level of activity during 
these attacks, it appeared that overall postural tone was diminished 
(Figures 4F,G), because animals leaning against a cage wall or 
feeder would often slide downward, but not fall suddenly to the 
floor of the cage (Figures 4H,I), as happens in cataplexy.
anatomical connections of the substantia  
nigra Pars reticulata and Pars compacta with 
the Mlr
Previous research has found that basal ganglia output from the SNr 
and GPi of the basal ganglia targets the area immediately medial to 
the PPT cholinergic group, a structure that was identified by Rye 
and colleagues (29) as the MEA. AS the MEA appears adjacent 
or may even overlap the MLR and PPT, we wanted to explore the 
relationship between the descending nigral (SNr) output systems, 
MLR, and PPT.
We first labeled the descending projection from the SNr 
using simultaneous injections of anterograde tracer biotinylated 
dextran amine (BD, 6 nl) into the SNr and FG into the ventral 
horn (C8-T1 level) to reveal the MLR spinally projecting neu-
rons (n = 3). We demonstrated that the BD-labeled terminals 
from the SNr targeted the MEA, which was just lateral to the 
dorsal MLR neurons and dorsal to the ventral MLR neurons 
(Figures 5A,B). Consistent with previous descriptions by Wainer, 
Rye, and colleagues (29, 30), the MEA was medial to the PPT, 
and thus, sandwiched between the MLR and PPT (Figures 5A,B). 
BD injected in the SNc terminated on the ventral MLR neurons 
(Figure 5C).
To further determine whether SNc neurons projecting to the 
vMLR were dopaminergic or non-dopaminergic, we injected CTB 
into the ventral MLR region in four rats, and then stained sections 
through the SNc immunohistochemically for TH and CTB. To 
our surprise, only a few of the CTB-ir neurons (<10%) in the 
SNc were TH positive. As the SNc contains both dopaminergic 
and GABAergic neurons, it is likely that the non-dopaminergic 
neurons were GABAergic. Consistent with this finding, few MLR 
neurons that were retrogradely labeled with FG after spinal cord 
injections (<5%) showed in  situ hybridization for D2 receptor 
mRNA (Figure 1E).
To dissect the neural pathway of the MLR in the spinal cord 
motor system, we injected pseudorabies virus (PRV) expressing 
green fluorescence protein (PRV-GFP; a retrograde transneuronal 
tracer) into the soleus (ankle extensor) or anterior tibial (ankle 
flexor) muscles. Rats were perfused at 120 h (n = 2 per muscle), 
168 h (n = 2 per muscle), and 192 h (n = 2 per muscle) after the 
PRV-GFP injections.
At 120 h, very few PRV-GFP retrogradely labeled neurons were 
observed in the VMM from rostral to caudal level after injections 
into either the flexor or extensor muscle (Table 1).
At 168 h after flexor PRV injection, PRV-GFP further labeled 
the VMM, and began to appear in the PAG and entire MLR as well 
as the MEA (Figure 6; Table 1). However, no PRV was seen in 
SNr or SNc. At 196 h after flexor PRV-GFP injections, PRV-GFP 
was highly expressed in the VMM, vlPAG, MEA, MLR, and RRF. 
PRV was seen in SNr but not SNc neurons (Figure 6; Table 1). At 
192 h, PRV-GFP expression in these regions was further enhanced. 
However, PRV-GFP was not seen in LDT or PPT cholinergic 
neurons (Table 1).
At 168 h after PRV injections in the extensor, a few PRV-GFP 
neurons were seen in the VMM. PRV-GFP appeared in the vMLR 
and SNc, but not in the MEA. At 196 h, more PRV-ir neurons were 
seen in the SNc but not in the SNr (Figure 7; Table 1), and PRV 
was highly expressed in the VMM, vlPAG, and MLR. However, 
PRV was not seen in the MEA (Figure 7; Table 1). At 196 h, PRV 
expression accumulated further in these regions. In addition, PRV 
was seen in the MEA, and some LDT cholinergic neurons, but not 
in PPT cholinergic neurons.
To determine the neural connectivity of the MLR in the cranial 
motor system, we injected PRV-GFP into the tongue, which has 
both flexor (retraction) and extensor (protrusion) muscles, and 
perfused rats after 72 h (n = 2) and 96 h (n = 2), respectively. Rats 
perfused after 72 h showed PRV-GFP labeled neurons in the entire 
MLR region and SNc as well as RRF (Figure 8); however, no PRV-ir 
cells were seen in the MEA or SNr. By 96 h, there was substantial 
PRV-GFP labeling of cells not only in the MLR, but also in the 
MEA, SNr, and SNc as well (Figure 8). We also observed many 
PRV-GFP neurons in the vlPAG, RVM, and VMM.
Taken together, these temporal patterns of PRV-GFP labeling 
in the pontine motor circuitry are consistent with flexor and 
extensor muscles being influenced by two separate neural circuits: 
(1) an extensor circuit that regulates posture (maintained mainly 
by extensors in the limbs) involving a inhibitory input from the 
SNc (GABAergic and dopaminergic neurons) to the ventral MLR, 
which then regulates posture; and (2) a flexor circuit, necessary 
for locomotion and performance of specific tasks, which involves 
an inhibitory projection from the GABAergic SNr to the MEA, 
mainly to the dorsal MLR. The MLR also regulates cranial motor 
behavior.
Figure 4 | OX-saP lesions of the Mlr produce cataplexy and 
complete akinesia. (a) shows lesions (circled) including the vMLR but not 
the dMLR. A cataplexy attack caused by vMLR lesions, characterized by 
entering directly from wakefulness to a state of desynchronized EEG and 
atonia, is seen at the arrow in (B). The animal is seen in a series of video 
images (c) showing an attack that begins while the animal is feeding, and 
results in him collapsing on the floor of the cage. The EEG resembles waking 
EEG not REM sleep EEG (high theta). (D) shows the duration and timing of a 
series of cataplexy attacks that occur during the dark period (7 p.m.–7 a.m.). 
Attack episodes vary from 20 to over 200 s in length. Lesions of the dMLR  
(e) produce freezing attacks or complete akinesia, in which the animal 
maintains the same posture throughout, despite being awake in the early part 
of the attack [EEG in (F) shows an awake pattern, photo in (h) is at time point 
indicated by asterisk] but falling asleep while frozen [EEG in (g) shows 
sleeping EEG, photo in (i) is at the time point indicated by the asterisk]. The 
bar shows duration of sleep EEG during the attack.
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Figure 5 | spatial relationship of the Mlr, Mea, and PPT. The MEA 
marked by black terminals of a biotinylated dextran (BD) injected into the SNr in 
both (a,B) situates lateral to the MLR marked brown by FG from the spinal 
cord in (a) and medial to the PPT, marked brown by ChAT-ir neurons in (B). 
The ventral MLR (FG) neurons (black arrows) and their dendrites (red arrows) 
are apposed by SNc terminal boutons (c).
June 2015 | Volume 6 | Article 1408
Sherman et al. Pontine motor circuit
Frontiers in Neurology | www.frontiersin.org
Discussion
The present study provides evidence that spinal-projecting neurons 
of the pontine tegmentum form, at least in part, the neuroana-
tomic basis of the MLR. This neuronal population specifically 
comprises reticulospinal glutamatergic cells that express high 
levels of the OX2 receptor. Consistent with this interpretation, 
bilateral chemical stimulation of the dorsal or ventral MLR neu-
rons induced rhythmic walking and erect posture, respectively, 
whereas cell-specific lesions produced cataplexy and immobility. 
Our study also reveals a potential critical role for the MLR as 
a link between basal ganglia output and spinal cord motor 
circuits. Collectively, these results provide a new perspective 
for the neuroanatomic basis of the MLR as well as providing a 
context for understanding motor disturbances associated with 
cataplexy and PD.
Mlr control of Motor Behavior
The MLR was originally defined on the basis of electrical stimula-
tion experiments, and hence its cellular identity was not well 
defined. Garcia-Rill and colleagues attempted to map sites that 
produced locomotion at low threshold, and found that the sites 
were located close to the cholinergic PPT (31, 32). Because PPT 
cholinergic neurons do not project directly to the spinal cord, 
the same investigators hypothesized that these neurons might 
influence locomotion by means of its projections to the ventral 
medulla (33). Skinner, Garcia-Rill, and colleagues found that 
injection of cholinergic agonist into the rostral ventromedial 
medulla (RVM, at the level of the facial nucleus) induced step-
ping behavior (25). However, the latency of agonist-induced 
stepping was long (5–10 min) and the duration short (5–10 s), 
which raises the possibility that stepping may have been triggered 
by a distant site controlled by the RVM. Consistent with this 
interpretation, our PRV-based transneuronal labeling revealed 
that PPT cholinergic neurons do not strongly project to the 
medulla. Interestingly, NMDA agonist in the RVM induced 
stepping with a short latency and long duration (1–5 min) (25), 
suggesting the possibility that glutamate inputs, possibly from 
the LPT, to the ventral medulla may be involved in regulation 
of locomotion. On the other hand, we found that lesions of 
the ventral medulla did not block locomotor activity or Fos 
immunoreactivity in spinal motor neurons induced by chemical 
stimulation of the MLR. Paradoxically, Lai, Siegel, and colleagues 
have consistently demonstrated that injections of cholinergic and 
glutamate agonists into the ventral medulla induce atonia (27, 
34–36). Chemogenetic activation of the RVM in rats also does 
not promote motor behavior (Chen, Fuller, and Lu, unpublished 
observations). Finally, cell body lesions of the ventral medulla do 
not produce cataplexy or immobility attacks (37). Thus, while the 
foregoing data, taken together, do not provide conclusive evidence 
that glutamate inputs from the LPT (or other supra spinal sites) 
are necessary for locomotion, they do suggest that the structural 
integrity of the ventral medulla is not required for the MLR to 
regulate motor behavior and, moreover, that the ventral medulla 
is more critically involved in the regulation of muscle tone control 
than locomotion.
It should be noted that since we did not specifically measure 
stepping behavior on a treadmill, we could not rule out the 
possibility that PPT cholinergic neurons are uniquely involved 
TaBle 1 | PrV-gFP-ir neurons (section/injection side) in the 
mesopontine-medulla motor circuitry.
Flexor (tibialis) extensor (soleus)
120 h 
(n = 2)
168 h 
(n = 2)
196 h 
(n = 2)
120 h 
(n = 2)
168 h 
(n = 2)
196 h* 
(n = 2)
RVM * ** *** * * ***
CMM * ** *** * * ***
vMLR – ** ***** – * *****
dMLR – **** ***** – – ****
MEA – ** ** – – *
SNc – – – – * ***
SNr – – ***** – – –
RRF – * ** – * **
LDT – – – – – *
PPT – – – – – –
*1–10 cells; **10–20 cells; ***20–30 cells; ****30–40 cells; *****40–50 cells.
Figure 6 | Temporal and spatial distribution of PrV-gFP from the tibialis anterior (Ta; flexor) muscle. At 168 h after PRV-GFP injections in TA, PRV-GFP 
preferentially labels the PAG, MLR, and MEA (a) as well as the VMM, but not the SNr (B). After 196 h, the PRV labeling from the TA shows more extensive labeling 
in the VMM (c) and SNr (D).
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in the regulation of stepping behavior. Furthermore, our study 
did not directly examine the role of PPT cholinergic neurons 
in locomotion nor does our experimental approach (including 
the lesions and stimulation experiments) allow us to exclude a 
contribution of PPT cholinergic neurons to locomotor control. 
We anticipate that the specific role and contribution of PPT 
cholinergic neurons in locomotion will be informed in future 
investigations using optogenetic and chemogenetic approaches. 
Our data do, however, continue to strongly support the concept 
that a population of glutamatergic spinally projecting neurons 
within the LPT, situated directly medially adjacent to the PPT, 
comprise a major structural element of the MLR. Additional and 
strong evidence in support of our hypothesis derives from our 
recent work, in which we performed extracellular recordings on 
spinally projecting neurons, verified by antidromic response to 
spinal cord stimulation, in the LPT of freely moving rats. In that 
we study, we demonstrated that non-cholinergic LPT neurons fired 
in bursts that were specifically associated with motor behavior, 
while non-spinally projecting neurons, including presumptive 
cholinergic PPT neurons, did not fire in association with motor 
behavior (12).
The anatomical results of the present study also suggest that 
spinally projecting neurons in the LPT may be the long-sought 
target of the descending projection of the basal ganglia. The 
descending pallidal and nigral descending projection was 
originally identified by Nauta and Mehler (38) as innervating the 
PPT, and this concept has been promulgated in many textbooks. 
Rather, and as Rye and colleagues have shown, the descending 
output of the SNr targets the MEA, (29) not the PPT, at least 
in rats. The MEA consists of small sized neurons, which are 
possibly local interneurons, but their targets have previously 
been unknown. Our transneuronal data indicate that spinally 
projecting neurons in the MLR are likely a major target of the 
MEA. Our results divide the spinally projecting neurons in the 
LPT into a ventral population involved in postural control, 
whose hypoactivity is associated with the postural collapse of 
cataplexy, and a dorsal population involved in locomotor facilita-
tion, whose hypoactivity is linked to immobile attacks in rats. 
These structures are influenced by disynaptic input from the 
SNr and GPi, which are relayed through the MEA. According 
to our proposed model of MLR function (Figure  1F), basal 
ganglia output directs MLR activity patterns in accordance with 
a selected motor program, conveying information as to which 
muscles require activation to move (via the dMLR) and which 
muscles require activation to maintain postural stability (via the 
vMLR). Striatal (direct) and pallidal (indirect) output would 
therefore inhibit the SNr, and thereby disinhibit appropriate por-
tions of the MEA, allowing for dMLR and vMLR activation and 
facilitating locomotion and postural enhancement, respectively, 
in the appropriate muscle groups.
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Our model would further predict that, through its axonal 
projections to the spinal cord, the MLR provides excitatory input 
to motor pattern generator neurons or to motor neurons or to both. 
The degree to which this is a direct projection or one that utilizes 
either spinal or ventromedial medullary interneurons in intact 
animals remains an important subject for future study. In addition, 
our understanding of the relationship between the MLR and spinal 
cord circuitry is far from complete, and further study is necessary 
to determine physical correlates of postural and locomotor control 
at the spinal cord level. Although we did not focus on MLR control 
of the cranial motor system, what we have shown is consistent 
with previous work in which injections of PRV were placed in 
the tongue (39). In addition, we found that chemical stimulation 
of the MLR induced vocalization and whisker movements in rats.
Mlr lesions cause cataplexy and akinesia
In further support of a role for MLR neurons in the control of 
muscle tone, we have observed that lesions of the MLR region 
facilitate cataplectic behavior. As the lesioned neurons express 
OX2 receptor mRNA, this finding links to the established role of 
orexin signaling in cataplexy, including the loss of orexin signaling 
in orexin knockout mice (40), dogs with OX2 receptor mutations 
(41), and human patients lacking orexin neurons (42). During 
short cataplectic attacks (under 30 s), the EEG of our rats did not 
change from the waking pattern; however, in many longer bouts, 
the EEG gradually transitioned into a slow pattern indicative of a 
non-REM sleep state. Cataplexy was particularly prominent after 
lesions of the vMLR. Many of the vMLR neurons express OX2 
receptors, which may, in part, explain why orexin deficiency would 
also make animals prone to cataplexy. Of note, PPT cholinergic 
neurons express OX1 receptors, which unlike OX2 receptors are 
not associated with cataplexy. On the other hand, lesions targeting 
the dMLR resulted in immobility attacks. The animals appeared 
unable to move during the attacks, which is consistent with the 
concept that the dMLR promotes locomotion. These findings are 
consistent with the idea that the MLR comprise two divisions, a 
dorsal group involved in locomotor facilitation and a ventral group 
involved in postural regulation.
Mlr and Parkinsonism
The immobility attacks seen in our rats with dMLR lesions are 
reminiscent of the gait freezing observed in PD. These observa-
tions suggest that in patients with PD, these same underlying 
neural circuits may contribute to akinesia by transmitting inhibi-
tory influences from hyperactive SNr neurons to the dMLR or 
possibly through lesions in the dMLR in PD (43). Our study has 
also shown that the vMLR is critically linked to postural muscle 
tone control, and this circuitry could contribute to rigidity in PD 
Figure 7 | Temporal and spatial distribution of PrV-gFP from the 
soleus (sOl; postural extensor). At 168 h after PRV-GFP injections in the 
SOL, PRV-GFP labels the PAG and vMLR and SNc (a,B). PRV-GFP-ir neurons 
are more abundant in the VMM and SNc after 196 h (c,D). These results 
suggest that for spinal motor control, the SNc- > vMLR projection may be 
more important for controlling extensor muscles (posture control), whereas the 
SNr- > MEA- > MLR projection may be more important for controlling flexor 
muscles, which are necessary for gait.
Figure 8 | Temporal and spatial distribution of PrV-gFP from the 
tongue. At 72 h after PRV-GFP injection, the MLR (a) and SNc (B) show 
PRV-GFP-ir neurons ipsilateral to the injection site. After 96 h, the labeling is 
more extensive (c,D), now including the MEA (c) and SNr (D). The temporal 
sequence of PRV labeling suggests that the SNc- > MLR pathway requires 
less time for labeling than the SNr- > MEA- > MLR pathway following tongue 
injections.
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patients, through loss of SNc GABAergic neurons, which may be 
necessary to break extensor tone. In the past, loss of SNc neurons 
has focused on dopaminergic neurons, but it is known that there is 
a large GABAergic population intermixed with the dopaminergic 
neurons, and their role has received relatively scant attention. On 
the other hand, alpha-synuclein deposits in the pons precede those 
in the substantia nigra (44, 45), so it is possible that the MLR and/
or MEA neurons may be damaged independently, and earlier in 
disease progression, to produce akinesia and posture instability. 
Again, the roles of these different cellular populations in PD 
require further study.
Patients with PD also have cranial motor symptoms, including 
a mask-like facial appearance, low volume speech, and difficulty 
swallowing. Our results indicate that the MLR region may also 
contribute to cranial nerve motor control, and that manipulations 
such as DBS in this region may also be effective for treating oro-
facial dysfunction of PD. Indeed, the entire basis for the effects of 
DBS in the PPT region may require a re-evaluation in terms of the 
type of neurons responsible for improvement in akinesia and gait 
that have been observed in both PD primate models and patients 
with PD (24, 46–48). In particular, a more detailed understanding 
of how basal ganglia influence the activity of the MLR may greatly 
inform the design of future treatments for PD.
Materials and Methods
animals
Pathogen-free, adult, male Sprague-Dawley rats (275–300  g, 
Harlan) were individually housed and had free access to food 
and water. All animals were housed under controlled conditions 
(12 h light starting at 07:00 a.m., 100 lux) in an isolated ventilated 
chamber maintained at 20–22°C. All protocols were approved by 
the Institutional Animal Care and Use Committee of Beth Israel 
Deaconess Medical Center.
Physiology
EEG/EMG Lead Implantation and Sleep Analysis
Rats were anesthetized with chloral hydrate (350 mg/kg), and the 
skull exposed. Four EEG screw electrodes were implanted into 
the skull, in the frontal (2) and parietal bones (2) of each side, 
and two flexible EMG wire electrodes were placed into the neck 
muscles. The free ends of the leads were soldered into a socket 
that was attached to the skull with dental cement, and the incision 
was closed using wound clips. One week after surgery, the sockets 
were connected via flexible recording cables and a commutator to 
a Grass polygraph and computer. Signals were digitized by a PC 
running Sleepsign recording (Kissei, Japan).
Three (Wake, NREM, and REM sleep) behavioral states were 
visually identified and analyzed in 10 s epochs for daily sleep-
wake cycle analysis. The behavioral states were classified in 
wake, characterized by high frequency, low-voltage EEG signals 
coupled with high levels of EMG activity EG; NREM sleep (NR) 
was characterized by high-amplitude, low-frequency EEG signals, 
and in the absence of motor activity; REM sleep was characterized 
by low-amplitude, high-frequency theta-like EEG activity, and 
muscle atonia.
histology and Tracing
Stereotaxic Injections of Tracers, OX-SAP
Under chloral hydrate anesthesia (7% in saline, 350 mg/kg), a fine 
glass pipette containing the tracers (1.0% Cholera toxin subunit 
B (CTB, List Biological), FG (5%), orexin-saporin (Advanced 
Targeting Systems) was lowered to the pre-calculated targets. 
Injections of 3–100 nl volumes were made over 10 min by an air 
pressure system. After two additional minutes, the pipette was 
slowly withdrawn and the incision was closed with wound clips. 
Animals survived for 7 days. Coordinates: LPT, AP = −7.6 mm, 
ML = 1.6 mm, DV = 7.2 mm; VRM, AP = −11.9 mm, ML = 0.0 mm, 
DV = 8.0 mm. FG was injected at T1 level.
PRV-GFP Injection
PRV-GFP-152 was the generous gift of Dr. Lynn Enquist (Princeton 
University, Princeton, NJ, USA). Individual aliquots were frozen at 
−80°C and thawed immediately before the injection. Animals were 
anesthetized with choral hydrate, and injections of 30 μl (109 pfu/
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ml) were placed either into the tongue muscles of right side or the 
leg muscles of right side, by using a 50 μl Hamilton syringe. In the 
leg injections, the right leg was shaved and the muscle groups were 
exposed, allowing injection of PRV-GFP into the soleus (extensor) 
or tibialis anterior (flexor) muscles under direct observation.
Ibotenic Acid Stimulation
For fast recovery from anesthesia, we anesthetized rats with 
isoflurane and injected 3 nl of ibotenic acid (10%) by air pressure 
in either the dorsal or ventral LPT (see above for coordinates). 
Wounds were closed with wound clips and rats woke up around 
5 min after the surgery.
Perfusion
Animals were deeply anesthetized by chloral hydrate (500 mg/
kg), then perfused with 50  ml saline, followed by 500  ml 10% 
formalin through the heart. The brains were removed, post-fixed 
for 4 h in 10% formalin, and then equilibrated in 20% sucrose in 
PBS overnight.
Immunohistochemistry
The brains were sectioned on a freezing microtome at 40 μm into 
four series. Sections were washed in 0.1M phosphate-buffered 
saline, pH 7.4 (PBS, two changes), and then incubated in the primary 
antiserum (rabbit polycolonal antibody agonist c-Fos, 1: 150,000, 
AB5, Oncogene Sciences; polycolonal goat antibody against ChAT, 
1:2000, AB144, Chemicon); goat anti- CTB, 1:100,000, catalog # 114, 
List Biological; rat anti-GFP 1:5000, catalog# 69050, Novagen) 
for 1 day at room temperature. The c-Fos antiserum was raised 
against a synthetic peptide representing residues 4–17 from human 
c-Fos. The ChAT antiserum was raised against human placental 
enzyme and recognized a single band of about 62 kD m.w. on 
Western blots of rat brain (manufacturer’s technical information). 
It stains a pattern of neuronal morphology and distribution in 
the rat mesopintine tegmentum consistent with previous reports 
(30). The CTB antibody was made against purified cholera toxin B 
subunit. It does not stain anything in uninjected brains. The GFP 
antiserum was raised against purified jellyfish GFP, and also does 
not stain anything in normal rat brains. Cre was raised against 
bacteriophage P1 Cre recombinase.
Sections were then washed in PBS and incubated in biotinylated 
secondary antiserum (against appropriate species IgG, 1:1,000 
in PBS) for 1 h, washed in PBS, and incubated in avidin-biotin-
horseradish peroxidase conjugate (Vector) for 1 h. Sections were 
then washed again and incubated in a 0.06% solution of 3,3-diam-
inobenzidine tetrahydrochloride (DAB, Sigma) plus 0.02% H2O2. 
The sections were stained brown with DAB only or black by adding 
0.05% cobalt chloride and 0.01% nickel ammonium sulfate to the 
DAB solutions.
For immunohistochemical controls for the secondary antibody, 
primary antibodies were omitted and the tissue showed no immu-
noreactivity above background.
In situ hybridization of VGLUT2 mRNA, D2 mRNA, 
and OX2 mRNA
This was done as in Marcus et al. (13). Sections were prepared as 
above for immunostaining (CTB, Fos, or FG), except that only 
DEPC treated solutions were used, and serum was omitted from 
incubations. Sections were then acetylated and hybridized overnight 
(55°C) with a 35S-labeled cRNA probe synthesized from a plasmid 
containing VGLUT2 (1615–1979 of GenBank entry AF271235), 
OX2 receptor (Dr. Marcus, Harvard Medical School), or D2 dopa-
mine receptor (gift from Dr. Weaver at UMASS, Worcester, MA, 
USA). After a succession of 1 h washes (2×SSC/1 mM DTT, 50°C; 
0.2×SSC/1 mM DTT, 55°C; 0.2×SSC/1 mM DTT, 60°C), the tissue 
was treated with RNase-A (Boehringer-Mannheim, Indianapolis) 
and washed under conditions of increasing stringency, including a 
30 min wash at 60°C in 0.1% SSC. The tissue was then dehydrated 
in alcohols and air-dried. Slides were developed in Kodak D-19, 
fixed, and then dehydrated, and coverslipped.
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